SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77328.19
516.33 (-0.66%)

Filter

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Zydus Lifesciences Ltd.	Q V PT	94,475 Mid Cap	938.90 (-0.13%)	19.16	3.6	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Yatharth Hospital & Trauma Care Services Ltd.	Q V+ PT	8,312 Small Cap	862.60 (4.86%)	84.73	4.96	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Wockhardt Ltd.	Q V+ PT	26,111 Small Cap	1,606.90 (-1.82%)	124.86	5.38	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Windlas Biotech Ltd.	Q V PT	1,732 Small Cap	820.55 (-4.24%)	27.11	3.29	18.24	17.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Wanbury Ltd.	Q V+ PT	887 Small Cap	254 (0.79%)	13.61	7.16	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Viyash Scientific Ltd.	Q V PT	9,568 Small Cap	219 (-1.26%)	126.15	10.77	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Vimta Labs Ltd.	Q V+ PT	2,289 Small Cap	512.45 (1.43%)	29.12	4.94	13.74	62.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Vijaya Diagnostic Centre Ltd.	Q V PT	12,359 Small Cap	1,278.15 (5.73%)	67.58	12.88	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Unichem Laboratories Ltd.	Q V PT	2,711 Small Cap	385.10 (-1.75%)	12.23	1.05	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,48,251 Large Cap	4,380.35 (0.49%)	64.93	16.24	7.72	15.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Thyrocare Technologies Ltd.	Q V PT	7,727 Small Cap	485.45 (3.60%)	45.75	11.16	9.62	-1.08	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Themis Medicare Ltd.	Q V PT	902 Small Cap	97.96 (-0.86%)	N/A	3.04	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Tarsons Products Ltd.	Q V+ PT	1,211 Small Cap	227.65 (-0.31%)	36.91	1.81	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Syngene International Ltd.	Q V+ PT	18,488 Small Cap	458 (-2.43%)	62.15	4.03	10.89	4.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Syncom Formulations (India) Ltd.	Q V PT	1,383 Small Cap	14.71 (-1.61%)	20.39	3.55	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Suven Life Sciences Ltd.	Q V+ PT	5,911 Small Cap	224.15 (1.56%)	N/A	3.78	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Suraksha Diagnostic Ltd.	Q V PT	1,516 Small Cap	291.05 (1.43%)	44.89	6.29	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Supriya Lifescience Ltd.	Q V PT	5,697 Small Cap	707.80 (1.06%)	30.43	4.98	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,43,229 Large Cap	1,847.30 (0.70%)	40.32	5.42	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,609 Small Cap	172.85 (3.53%)	N/A	-12.62	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Strides Pharma Science Ltd.	Q V+ PT	10,654 Small Cap	1,155.85 (0.99%)	57.52	3.2	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Solara Active Pharma Sciences Ltd.	Q V PT	2,531 Small Cap	525.45 (1.86%)	N/A	2	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	SMS Pharmaceuticals Ltd.	Q V+ PT	3,886 Small Cap	414.90 (-1.36%)	45.11	5.03	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Sigachi Industries Ltd.	Q V+ PT	841 Small Cap	22.01 (4.96%)	N/A	1.7	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Shree Ganesh Remedies Ltd.	Q V PT	681 Small Cap	530.60 (8.65%)	34.63	4	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Shilpa Medicare Ltd.	Q V PT	8,532 Small Cap	436.25 (-1.26%)	57.59	3.47	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Shalby Ltd.	Q V PT	1,822 Small Cap	168.70 (0.75%)	24.37	1.52	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Senores Pharmaceuticals Ltd.	Q V+ PT	4,451 Small Cap	966.55 (3.66%)	311.4	5.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Sanofi India Ltd.	Q V PT	7,664 Small Cap	3,327.85 (-1.90%)	25.22	10.02	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,993 Small Cap	4,773 (0.28%)	42.5	24.26	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Metropolis Health.	550.30	8.83%
Shree Ganesh Remed.	530.60	8.65%
KMC Speciality Hosp	95.47	6.85%
Guj. Kidney & Super	139.85	6.84%
Nectar Lifesciences	14.39	5.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Indoco Remedies	228.20	-9.17%
Windlas Biotech	820.55	-4.24%
Panacea Biotec	388.15	-4.16%
Fermenta Biotech	288.70	-4.07%
Lupin	2,377.90	-3.33%

News about Top Pharma Companies in India

May, 2026

Thyrocare Tech. - Quaterly Results

The Revenue for the quarter ended March 2026 of Rs. 2106.70 millions grew by 21.17 % from Rs. 1738.70 millions.Profit for the quarter ended March 2026 rises by 98.54% to Rs. 435.80 millions from Rs. 219.50 millions.The company reported a good operating profit of 763.50 millions compared to 601.80 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	2106.70	1738.70	21.17	7742.70	6331.00	22.30	7742.70	6331.00	22.30
Other Income	37.20	45.40	-18.06	133.90	133.40	0.37	133.90	133.40	0.37
PBIDT	763.50	601.80	26.87	2697.20	2003.60	34.62	2697.20	2003.60	34.62
Interest	14.30	6.00	138.33	21.80	26.30	-17.11	21.80	26.30	-17.11
PBDT	749.20	595.80	25.75	2615.70	1977.30	32.29	2615.70	1977.30	32.29
Depreciation	129.40	117.80	9.85	511.70	465.20	10.00	511.70	465.20	10.00
PBT	619.80	478.00	29.67	2104.00	1512.10	39.14	2104.00	1512.10	39.14
TAX	184.00	258.50	-28.82	615.90	554.30	11.11	615.90	554.30	11.11
Deferred Tax	23.50	114.20	-79.42	43.00	76.60	-43.86	43.00	76.60	-43.86
PAT	435.80	219.50	98.54	1488.10	957.80	55.37	1488.10	957.80	55.37
Equity	1591.70	529.90	200.38	1591.70	529.90	200.38	1591.70	529.90	200.38
PBIDTM(%)	36.24	34.61	4.71	34.84	31.65	10.07	34.84	31.65	10.07

May, 2026

Vimta Labs - Quaterly Results

The revenue zoomed 15.68% to Rs. 1092.45 millions for the quarter ended March 2026 as compared to Rs. 944.41 millions during the corresponding quarter last year.A humble growth in net profit of 15.25% reported in the quarter ended March 2026 to Rs. 211.13 millions from Rs. 183.19 millions.Operating profit for the quarter ended March 2026 rose to 421.19 millions as compared to 346.77 millions of corresponding quarter ended March 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	1092.45	944.41	15.68	4072.90	3439.82	18.40	4072.90	3439.82	18.40
Other Income	27.51	16.40	67.74	89.89	42.40	112.00	89.89	42.40	112.00
PBIDT	421.19	346.77	21.46	1505.08	1261.89	19.27	1505.08	1261.89	19.27
Interest	3.21	4.38	-26.71	11.67	19.00	-38.58	11.67	19.00	-38.58
PBDT	417.98	342.39	22.08	1477.25	1242.89	18.86	1477.25	1242.89	18.86
Depreciation	127.51	92.12	38.42	437.72	352.89	24.04	437.72	352.89	24.04
PBT	290.47	250.27	16.06	1039.53	890.00	16.80	1039.53	890.00	16.80
TAX	79.34	67.08	18.28	264.41	222.45	18.86	264.41	222.45	18.86
Deferred Tax	16.91	-2.58	-755.43	-1.07	12.66	-108.45	-1.07	12.66	-108.45
PAT	211.13	183.19	15.25	775.12	667.55	16.11	775.12	667.55	16.11
Equity	89.34	44.47	100.90	89.34	44.47	100.90	89.34	44.47	100.90
PBIDTM(%)	38.55	36.72	5.00	36.95	36.68	0.73	36.95	36.68	0.73

May, 2026

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

The inspection closed with seven observations

May, 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has enclosed a copy of press release dated May 6, 2026, titled ‘USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Sanofi Consumer Healthcare India informs about disclosures

Sanofi Consumer Healthcare India has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Zydus Lifesciences informs about updates

Zydus Lifesciences has informed that it enclosed Receipt of Demand Order-In-Original from Deputy Commissioner of CGST & Central Excise, Ahmedabad North Commissionerate by Zydus VTEC, a wholly owned subsidiary company.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Zydus Lifesciences Ltd.	94,475 Crore
2	Yatharth Hospital & Trauma Care Services Ltd.	8,312 Crore
3	Wockhardt Ltd.	26,111 Crore
4	Windlas Biotech Ltd.	1,732 Crore
5	Wanbury Ltd.	887 Crore
6	Viyash Scientific Ltd.	9,568 Crore
7	Vimta Labs Ltd.	2,289 Crore
8	Vijaya Diagnostic Centre Ltd.	12,359 Crore
9	Unichem Laboratories Ltd.	2,711 Crore
10	Torrent Pharmaceuticals Ltd.	1,48,251 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,661	56,654	37.17	12.91	26.02	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,380	1,48,251	65.25	16.32	36.87	26.68
Ajanta Pharma Ltd. (S)	Very Good	3,032	37,883	35.87	8.37	24.25	24.45
Lupin Ltd. (M)	Somewhat Good	2,378	1,08,721	20.39	4.84	11.79	20.83
Zydus Lifesciences Ltd. (M)	Very Good	939	94,475	19.13	3.60	11.91	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,229	66,373	110
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,364	66,722	67.00
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,152	34,551	40.02
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,380	1,48,251	37.62
Gland Pharma Ltd. (S)	Very Good	1,904	31,377	34.73
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,152	34,551	47.50	8.85	30.00	17.81
Mankind Pharma Ltd. (M)	Very Good	2,427	1,00,200	58.82	6.28	35.25	14.65
Laurus Labs Ltd. (M)	Very Good	1,229	66,373	74.68	12.52	37.46	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,293	1,07,942	19.38	2.90	11.65	13.26
Ajanta Pharma Ltd. (S)	Very Good	3,032	37,883	35.87	8.37	24.25	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	939	94,475	19.13	3.60	11.91	30.57
Cipla Ltd. (L)	Very Good	1,348	1,08,865	23.95	3.24	14.44	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,847	4,43,229	40.61	5.46	22.21	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,293	1,07,942	19.38	2.90	11.65	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,152	34,551	47.50	8.85	30.00	19.45

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Thyrocare Tech. - Quaterly Results

Vimta Labs - Quaterly Results

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

Zydus Lifesciences informs about press release

Sanofi Consumer Healthcare India informs about disclosures

Zydus Lifesciences informs about updates

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.